Full Text View
Tabular View
No Study Results Posted
Related Studies
Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology
This study is currently recruiting participants.
Study NCT00315263   Information provided by Children's Mercy Hospital Kansas City
First Received: April 14, 2006   Last Updated: July 31, 2009   History of Changes

April 14, 2006
July 31, 2009
April 2006
 
 
 
Complete list of historical versions of study NCT00315263 on ClinicalTrials.gov Archive Site
 
 
 
Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology
Genomics, SNPs, and Clinical Neonatology

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).

This genetic predisposition study does not involve investigational drugs, devices, or treatments. Our broad goal is to identify genomic factors, which contribute to the development or exacerbation of common and critical illnesses that affect preterm and near-term infants. We seek to accomplish this goal in the following ways:

  • First: to test candidate gene DNA variations and link already identified single nucleotide polymorphisms (SNPs) producing functional alterations to the risk of clinically important disorders.
  • Second: to utilize a whole-genomic approach to identify SNPs not previously linked to the risk of development or progression of neonatal disorders.
 
Observational
Case Control, Prospective
  • Lung Disease
  • Brain Injury
  • Necrotizing Enterocolitis
  • Respiratory Failure
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
450
April 2010
 

Inclusion Criteria:

  • Less than 34 weeks gestation and less than 1500 g at birth
  • Greater than or equal to 36 weeks gestation and either with hypoxic respiratory failure or with mild respiratory distress never requiring assisted ventilation

Exclusion Criteria:

  • Life threatening anomalies of any organ system (e.g., cardiac, thoracic, lethal, or non-lethal chromosomal abnormalities)
Both
 
No
Contact: William E Truog, MD 816-234-3592 wtruog@cmh.edu
Contact: Michael Norberg, BS, MDiv 816-235-1981 mnorberg@cmh.edu
United States
 
NCT00315263
William Truog, MD, Principal Investigator, The Children's Mercy Hospitals and Clinics
01.3965
Children's Mercy Hospital Kansas City
University of Kansas
Principal Investigator: William E Truog, MD Children's Mercy Hospital Kansas City
Children's Mercy Hospital Kansas City
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP